Sensex Surges Over 600 Points, Nifty Above 14,750 Led By ITC
Shares recovered from early falls to trade slightly higher on Friday in a volatile session, as a pullback in U.S. Treasury yields from 14-month highs hit overnight eased some fears over foreign fund outflows from emerging markets. The blue-chip NSE Nifty 50 index was up 1.45 per cent to 14,769.10 and the benchmark S&P BSE Sensex rose 1.44 per cent to 49,924.45 Earlier in the session, the Sensex and Nifty shed up to 1.43 per cent and 1.28 per cent, respectively. "There is some easing in U.S. 10-year bond yields after hitting a peak. That has added to the risk appetite of traders who were looking to buy into the dips," said Anand James, chief market strategist at Geojit Financial Services in Kochi.     Â
"From a technical perspective, the Nifty found some support at the 14,500 level," said Amit Shah, head of India equities at BNP Paribas India in Mumbai. A surge in domestic cases of COVID-19 has also weighed on investor sentiment this week. India reported 39,276 cases on Friday, its highest daily rise since late November.
Main stock indexes were on track to post a drop of roughly three per cent for the week after two straight weeks of gains. As of Thursday's close, both the Nifty and Sensex were off roughly 5% from their record closing highs hit in mid-February.
Among individual stocks, Future Group companies, including Future Retail and Future Consumer, dropped nearly 10 per cent each. The court on Thursday restrained Future Group chief Kishore Biyani from selling his personal assets following Amazon.com Inc's challenge against the Indian group's $3.4 billion sale of its retail business to Reliance Industries.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.